ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,350,000 | -14.8% | 129,864 | +76.6% | 0.01% | -18.2% |
| Q4 2020 | $3,931,000 | +30.3% | 73,534 | +0.6% | 0.01% | 0.0% |
| Q3 2020 | $3,016,000 | -10.8% | 73,119 | +4.8% | 0.01% | -15.4% |
| Q2 2020 | $3,382,000 | -18.0% | 69,770 | -28.6% | 0.01% | -43.5% |
| Q1 2020 | $4,126,000 | +38.9% | 97,661 | +40.7% | 0.02% | +43.8% |
| Q4 2019 | $2,970,000 | +551.3% | 69,426 | +447.7% | 0.02% | +433.3% |
| Q3 2019 | $456,000 | – | 12,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |